Semax and N-Acetyl Semax — The Gold Standard Nootropic Peptides

There is a meaningful difference between compounds that make you feel like your brain is working better and compounds that actually change the biological infrastructure through which your brain works. Most nootropics caffeine, racetams, adaptogens belong in the first category. They alter neurochemistry in the moment, producing effects that last as long as the compound is active and leave the underlying biology essentially unchanged.

Semax belongs in the second category. And the distinction matters enormously for understanding both what it does and why people who use it tend to stay with it.

Semax is a synthetic heptapeptide analogue of the adrenocorticotropic hormone fragment 4 to 10, developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in the early 1980s. It is one of the most thoroughly studied nootropic peptides in existence, with a clinical history spanning over three decades in Russian medicine. Vivere

Semax is approved in Russia and Ukraine as a prescription medication for stroke recovery, cognitive enhancement, optic nerve atrophy and peptic ulcer disease. That regulatory approval in a jurisdiction with a rigorous pharmaceutical development process and three decades of clinical use gives Semax a human evidence base that most research peptides in this library simply do not have. It is not a speculative compound with compelling preclinical data. It is a clinically used medicine in two countries whose research into nootropic peptides has led the world for half a century. HighPeptides

N-Acetyl Semax is the acetylated derivative of the base compound, a modification that improves stability, enhances blood-brain barrier penetration and produces a more potent and longer-lasting effect from the same dose. Understanding when each form is appropriate is one of the most practically useful things this page can establish.

What Are Semax and N-Acetyl Semax?

Semax — Met-Glu-His-Phe-Pro-Gly-Pro — is a seven amino acid synthetic peptide derived from the ACTH 4 to 10 fragment of adrenocorticotropic hormone. The ACTH fragment was chosen as the starting point because research identified that this specific region of the ACTH molecule produced cognitive and neuroprotective effects independently of ACTH’s primary hormonal actions on the adrenal glands. Semax was designed to capture those neural effects while completely eliminating the hormonal profile of the parent molecule.

Semax is designed to cross the blood-brain barrier while avoiding the hormonal effects of ACTH. Instead, it improves overall brain health and enhances cognitive performance via interaction with dopamine, serotonin and enkephalin signalling, and elevation of brain-derived neurotrophic factor and nerve growth factor levels. Bachem

N-Acetyl Semax adds an acetyl group to the N-terminus of the base peptide. This alteration modulates its interaction with substances like copper ions and redox agents, possibly enhancing its stability in the process. In practical terms, N-Acetyl Semax is more resistant to enzymatic degradation after nasal administration, reaches the brain in higher concentrations and produces effects that are approximately 1.5 to 2 times more potent per unit dose than base Semax. Bachem

N-Acetyl Semax Amidate — sometimes called NASA-Semax — adds both an acetyl group and an amide group, producing the most potent and longest-lasting variant at approximately 2 to 3 times the potency of base Semax. It is the form most appropriate for experienced researchers who have established their response to the base compound or the N-Acetyl form and want the maximum effect per dose.

How Do Semax and N-Acetyl Semax Work?

The mechanism of Semax is one of the most thoroughly characterised of any compound in the Brain and Mood section — and the depth of that characterisation is part of what makes it so compelling.

BDNF and NGF Upregulation

This is the central and most significant mechanism. Glazova and colleagues at the Russian Academy of Sciences demonstrated dose-dependent increases in BDNF mRNA expression following intranasal Semax administration. Peak BDNF upregulation occurs 3 to 8 hours post-administration and remains elevated for 24 hours. This long-lasting neurotrophin response, despite the peptide’s 2 to 3 minute plasma half-life, is the pharmacological basis for once to three times daily dosing rather than continuous infusion. PeptideWiki

The significance of this finding is worth dwelling on. Semax clears from the plasma within minutes. Yet it produces BDNF upregulation that persists for 24 hours. The compound is not producing its effects by being present it is producing them by triggering a gene expression cascade that continues long after the peptide itself has gone. This is not the same biology as a conventional nootropic that works while it is in your system. It is a different class of intervention entirely.

The rapid hippocampal BDNF-mRNA tripling and TrkB phosphorylation increase after a single intranasal dose is well-replicated in animals and provides the mechanistic backbone for most of Semax’s clinical claims. This BDNF upregulation is the key differentiator versus most Western nootropics, which generally produce more subtle neurochemical changes at comparable doses. My WordPress

Neurotransmitter Modulation

Semax modulates multiple neurotransmitter systems relevant to cognition. Dopaminergic effects include enhanced dopamine synthesis and release in the striatum and prefrontal cortex and increased tyrosine hydroxylase expression, contributing to improved motivation, attention and working memory. Serotonergic effects include modulation of tryptophan hydroxylase activity and serotonin transporter function, contributing to mood regulation and Semax’s mild anxiolytic properties. Cholinergic effects occur through NGF-mediated support of basal forebrain cholinergic neurons, indirectly enhancing cholinergic transmission central to memory and attention. Exploring Peptides

Neuroprotection

Semax demonstrates robust neuroprotective effects in models of cerebral ischaemia, traumatic brain injury and neurotoxicity. The mechanisms involve both direct cellular protection against oxidative stress and indirect protection through the neurotrophic support of neurons that would otherwise become vulnerable under conditions of metabolic stress or injury. Exploring Peptides

Melanocortin Receptor Activity

Semax’s parent molecule ACTH acts through melanocortin receptors. The ACTH 4 to 10 fragment retains melanocortin activity that influences attention, learning and memory without the adrenal steroidogenic effects of full-length ACTH. This melanocortin component adds a dimension to Semax’s mechanism that is distinct from the neurotrophic effects — contributing to the acute attentional and processing speed improvements that users report alongside the more gradual neurotrophic benefits. HighPeptides

What Does the Research Show?

The evidence base for Semax is one of the most substantial in this library, spanning controlled human clinical trials, neuroimaging studies and decades of clinical use in Russian and Ukrainian medicine.

Stroke Recovery and Neuroprotection

In a trial involving 110 stroke patients, intranasal administration of Semax in two 10-day courses of 6,000mcg per day showed increased plasma BDNF levels, improved motor performance and enhanced functional independence. Bachem

Cognitive Enhancement in Healthy Subjects

Controlled studies showed Semax improved attention, memory and cognitive processing speed in healthy volunteers after 10-day intranasal courses. Advanced ChemTech

In a pilot study involving 24 healthy subjects, intranasal Semax increased resting fMRI signal in the default mode network rostral subcomponent relative to placebo — a neuroimaging finding that provides objective biological evidence of altered brain network activity in healthy people, not just in disease states. Vivere

Alzheimer’s Disease Models

A 2025 Russian study in Acta Naturae tested Semax and a derivative in an Alzheimer’s disease mouse model and found both peptides improved cognitive function. This extends the mechanistic picture into neurodegeneration but remains preclinical. PeptideWiki

Safety Profile

Decades of pharmaceutical use in Russia without major reported adverse effects is the best available long-term safety signal. Formal long-term Western safety trials do not exist. The safety profile appears clean in the published literature with no major adverse effects, no known addiction potential and no reported withdrawal syndrome. PeptideWiki

Who Is Semax Most Relevant For?

Semax is relevant to a specific and clearly definable group of people, and being precise about who that is makes it a much more useful compound than treating it as a general cognitive booster.

It is most relevant for professionals and high performers in their 30s to 60s who work in cognitively demanding fields and who notice that their mental performance under sustained load is not what it was or who want to maintain it at a high level as they age. These are people for whom mental performance is not a nice-to-have but a professional necessity, and who want an intervention that works with the neurotrophic infrastructure of their cognitive capacity rather than simply stimulating it chemically.

It is compelling for people who have tried conventional nootropics and found their effects either insufficient, unsustainable or too accompanied by unwanted side effects. The absence of dependence potential, withdrawal effects or the tolerance development that stimulant-based nootropics produce is practically significant for anyone who has experienced those limitations.

It is specifically relevant for anyone dealing with the cognitive consequences of chronic stress not through its anxiolytic mechanism, which is more the territory of Selank, but through the neuroprotective and BDNF-supporting effects that help the hippocampus and prefrontal cortex maintain their function under conditions that chronic stress impairs.

It is less appropriate as an acute performance enhancer for someone who wants a boost before a specific event. The most meaningful benefits of Semax develop over days and weeks of consistent use rather than hours after a single dose. Someone expecting the experience of a stimulant will find Semax disappointing. Someone investing in their cognitive baseline over a sustained protocol will find it one of the most meaningful compounds in the library.

Dosage and Protocol

Base Semax — Intranasal Protocol:

Dose: 200 to 600mcg per administration, one to three times daily
Standard cognitive enhancement dose is 600 to 1,200mcg per day intranasally via 0.1% solution, typically split across the day. PeptideWiki
Timing: Morning administration for focus and cognitive performance during the day. A second dose mid-morning or early afternoon for sustained effect. Avoid late evening administration as mild stimulant properties can interfere with sleep onset
Cycle length: 10-day courses are the most commonly used structure, reflecting the clinical trial protocols. Some researchers use continuous daily administration for 4 to 8 weeks. Most protocols incorporate rest periods of equal length between cycles
Administration route: Intranasal nasal spray — the standard and preferred route. See the intranasal preparation guide below

N-Acetyl Semax — Intranasal Protocol:

Dose: 100 to 300mcg per administration, one to two times daily — the enhanced potency of the acetylated form means effective doses are lower than base Semax
Timing: Same as base Semax — morning and mid-morning administration, avoiding late evening
Who it is most appropriate for: Those who have completed at least one cycle of base Semax and want greater potency per dose, or those who find base Semax produces the desired effects but at an inconveniently high dose volume

N-Acetyl Semax Amidate:

Dose: 50 to 200mcg per administration — the most potent form requiring the lowest absolute dose
Appropriate for: Experienced researchers who have used both base and N-Acetyl forms and want the maximum available potency

Intranasal Preparation and Administration Guide

This section differs fundamentally from the reconstitution guides elsewhere in this library because intranasal administration requires different materials and a different preparation process from subcutaneous injection.

Critical point — do not use bacteriostatic water for intranasal Semax. Bacteriostatic water contains benzyl alcohol as a preservative, which irritates nasal mucosal membranes and is inappropriate for intranasal administration. Use sterile saline solution or preservative-free sterile water instead.

What you need:

Lyophilised Semax powder vial
Sterile saline solution or preservative-free sterile water
A small nasal spray bottle specifically a nasal atomiser designed for peptide administration, available from specialist suppliers
A syringe for transferring the reconstituted solution into the nasal spray bottle

Reconstitution for a 0.1% solution — the standard cognitive enhancement concentration:

To make a 0.1% Semax solution from a 5mg vial:

Add 5ml of sterile saline to the 5mg vial
This produces 5ml of 0.1% solution containing 1,000mcg per ml
Each standard nasal spray pump delivers approximately 100mcg per spray at this concentration
A 200mcg dose = 2 sprays, a 300mcg dose = 3 sprays

To make a 1% solution — used in stroke recovery clinical protocols:

Add 0.5ml of sterile saline to the 5mg vial
This produces 0.5ml of 1% solution containing 10,000mcg per ml
This concentration is significantly higher than standard cognitive enhancement protocols and should not be used without specific clinical guidance

Administration method:

Transfer the reconstituted solution into the nasal atomiser. Administer one spray per nostril, alternating nostrils between doses or administering to both nostrils simultaneously depending on the total dose required. Breathe gently through the nose after administration rather than sniffing sharply, which reduces the amount of solution reaching the olfactory epithelium where absorption occurs.

Storage

Reconstituted Semax solution should be refrigerated at 2 to 8 degrees Celsius. Given that sterile saline rather than bacteriostatic water is used, the reconstituted solution has a shorter stable shelf life than bacteriostatic water-reconstituted compounds. Use within 14 days of reconstitution. Lyophilised powder should be stored frozen until ready for reconstitution to preserve maximum potency.

Supporting Supplements

The supplements that most coherently support Semax’s neurotrophic and neuroprotective mechanism are those that complement BDNF signalling, support the neurotransmitter systems the compound modulates and maintain the neurochemical environment in which its effects are most productive.

Lion’s Mane Mushroom is the most directly complementary supplement alongside Semax. It independently upregulates NGF — nerve growth factor through a different pathway from Semax’s mechanism, creating a complementary dual neurotrophic support approach. The combination of Semax upregulating BDNF and NGF through one pathway and Lion’s Mane supporting NGF through a separate pathway is one of the most biologically coherent nootropic supplement pairings available.

Omega-3 fatty acids — specifically DHA — are essential for neuronal membrane integrity, synaptic plasticity and BDNF signalling. DHA deficiency directly impairs the TrkB receptor signalling that BDNF activates and that Semax is working to upregulate. Adequate omega-3 intake is not optional alongside Semax; it is a prerequisite for the compound’s primary mechanism to operate fully.

Magnesium L-threonate is the most brain-penetrant form of magnesium and directly supports the synaptic plasticity and long-term potentiation that BDNF signalling drives. Research has demonstrated that magnesium L-threonate increases synaptic density in the hippocampus — a finding directly relevant to the neuroplasticity mechanisms Semax supports.

Vitamin B complex — particularly B6, B9 and B12 — supports neurotransmitter synthesis across the dopaminergic, serotonergic and cholinergic systems that Semax modulates. Deficiency in any of these vitamins directly impairs the neurotransmitter pathways the compound is working to optimise.

Vitamin D maintains neurological health and has specific relationships with BDNF expression and neuroinflammation that make it particularly relevant alongside a compound whose primary mechanism involves neurotrophic factor upregulation.

Alpha GPC or CDP-Choline provides the choline substrate for acetylcholine synthesis, directly supporting the cholinergic system that Semax’s NGF-mediated effects are working to maintain and enhance.

Foods That Complement Semax

The nutritional approach that best supports Semax’s neurotrophic and neuroprotective mechanism provides both the raw materials for neurotransmitter synthesis and the anti-inflammatory environment in which BDNF signalling operates most effectively.

Oily fish consumed two to three times per week is the most important single dietary priority alongside Semax. Salmon, mackerel, sardines and herring deliver the DHA that neuronal membranes require for the synaptic plasticity that BDNF signalling drives. No supplement form of omega-3 fully replicates the bioavailability and comprehensive fatty acid profile of whole oily fish.

Eggs provide choline, complete protein and leucine alongside B vitamins, a comprehensive neurological support package that complements Semax’s multi-pathway mechanism. The choline content is directly relevant to the cholinergic component of Semax’s mechanism.

Blueberries and dark berries — one of the most consistently evidenced dietary factors for cognitive health and BDNF support. The flavonoids in blueberries directly cross the blood-brain barrier and have been shown to upregulate BDNF expression, creating a dietary complement to Semax’s primary mechanism.

Dark leafy greens — spinach, kale, rocket — deliver folate, magnesium and the full spectrum of B vitamins that neurotransmitter synthesis requires, alongside antioxidants that reduce the neuroinflammation that impairs cognitive function.

Dark chocolate with a high cocoa content — the flavanols in cocoa have demonstrated BDNF-supporting and blood flow-enhancing effects in the brain, making it one of the most evidence-aligned dietary pleasures for anyone using Semax for cognitive enhancement.

Refined sugars, ultra-processed foods and alcohol all promote neuroinflammation, impair BDNF expression and disrupt the neurotransmitter balance that Semax is working to optimise, worth minimising throughout any Semax protocol.

Lifestyle Considerations

Sleep quality is the lifestyle factor that matters most alongside Semax, and the relationship is more specific than simply “sleep is good for the brain.” BDNF expression is strongly coupled to sleep architecture. Deep slow-wave sleep specifically drives the BDNF-dependent processes of memory consolidation, synaptic strengthening and the clearance of the metabolic waste products that accumulate during waking cognitive activity. Semax upregulates BDNF during waking hours. Sleep is where the downstream processes that BDNF signalling has initiated are completed. The two are not separate interventions — they are sequential phases of the same biological process.

Mental challenge and learning — this is the lifestyle consideration most unique to the Brain and Mood section. BDNF upregulation is most productive in a brain that is being given something to do with the enhanced neuroplasticity the compound is creating. Learning a new skill, engaging with genuinely challenging intellectual work, practising a musical instrument, studying a language these activities create the neural demand that BDNF-driven plasticity can respond to. Semax without cognitive challenge is analogous to CJC-1295 without resistance training. The mechanism is there but the stimulus for adaptation is absent.

Stress management is directly relevant given chronic stress’s well-documented suppression of hippocampal BDNF expression and the cortisol-mediated structural changes in the prefrontal cortex. The neuroprotective effects of Semax are most meaningful in someone who is also actively managing the chronic stress that constitutes the most significant ongoing threat to the brain structures Semax is working to support.

Exercise — aerobic exercise is one of the most robustly evidenced natural BDNF upregulators available. The combination of exercise-driven BDNF elevation and Semax-driven BDNF elevation creates a synergistic neurotropic environment that is greater than either produces alone. Regular aerobic exercise is not peripheral to a Semax protocol — it is complementary to its primary mechanism.

Compound Pairing

Selank is the most coherent and most commonly used pairing with Semax in the Brain and Mood section. The two compounds address genuinely complementary dimensions of brain function — Semax working through BDNF upregulation, neurotransmitter modulation and neuroprotection, Selank working through HPA axis recalibration, GABA modulation and anxiety reduction. For someone whose cognitive performance is impaired by both insufficient neurotrophic support and chronic anxiety or stress, the combination addresses both underlying biological problems simultaneously. The two compounds are frequently used together in Russian clinical practice.

Dihexa is sometimes paired with Semax in advanced cognitive enhancement protocols — Semax upregulating BDNF and supporting neurotrophic infrastructure while Dihexa drives the synaptogenesis that creates new structural connections between neurons. The two mechanisms are genuinely complementary rather than redundant.

BPC-157 pairs with Semax through the gut-brain axis. BPC-157’s gut-protective and systemic anti-inflammatory effects create a less inflammatory systemic environment in which BDNF signalling and neuroplasticity operate more effectively.

Lion’s Mane mushroom — already covered in supplements functions as a dietary complement rather than a research peptide pairing, but deserves mention here for the coherence of its NGF-supporting mechanism alongside Semax’s BDNF focus.

Realistic Expectations

Semax is the most thoroughly evidenced nootropic peptide in this library and the only one with regulatory approval as a prescription medicine in any jurisdiction. The results it produces are genuine, meaningful and well-documented, and they are also gradual, cumulative and quite different from the acute experience of conventional stimulant-based cognitive enhancement.

The most consistently reported experience across the research community and the clinical literature is a progressive shift in cognitive baseline over the course of a 10-day to 4-week protocol. Focus becomes more sustained. Verbal fluency improves. Memory retrieval feels less effortful. The mental fatigue that comes from sustained cognitive load arrives later and is less pronounced. These are not dramatic acute effects. They are a quieter but more fundamental kind of improvement, the kind that comes from a brain whose neurotrophic infrastructure is better supported.

For those who approach Semax with accurate expectations, consistent daily use, the sleep quality and cognitive challenge that amplify its effects, and the nutritional support its mechanism requires, it consistently delivers what the research predicts. A cognitive baseline that is genuinely better than before, maintained through a mechanism that works with the biology of the brain rather than simply altering its chemistry in the moment.

Semax and N-Acetyl Semax — The Gold Standard Nootropic Peptides